Finance

Lists
RPGLIFE:NSE
RPG Life Sciences Ltd
₹2,595.00
-0.13%
(-3.50) 1D
Nov 5, 12:25:43 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹2,624.20
High
₹2,634.00
Low
₹2,586.00
Mkt. cap
42.92B
Avg. vol.
38.87K
Volume
3.29K
Dividend
0.92%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
38.66
52-wk high
₹3,127.80
52-wk low
₹1,733.00
EPS
₹67.13
Shares outstanding
16.54M
No. of employees
1K
Open
₹2,624.20
High
₹2,634.00
Low
₹2,586.00
Mkt. cap
42.92B
Avg. vol.
38.87K
Volume
3.29K
Dividend
0.92%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
38.66
52-wk high
₹3,127.80
52-wk low
₹1,733.00
EPS
₹67.13
Shares outstanding
16.54M
No. of employees
1K
News stories
From web sources and news partners
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.37K
Founded1993
Headquarters-
SectorPharmaceutical industry
Industry-
Last report
Oct 30, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
1.97B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.80B
1.77B
1.96B
1.97B
Cost of goods sold
649.00M
661.00M
681.50M
702.80M
Cost of revenue
649.00M
661.00M
681.50M
702.80M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353.20M
570.90M
377.60M
396.10M
Operating expense
807.50M
835.00M
901.50M
960.20M
Total operating expenses
1.46B
1.50B
1.58B
1.66B
Operating income
343.80M
273.30M
373.90M
308.60M
Other non operating income
34.10M
-101.90M
47.00M
-
EBT including unusual items
291.20M
402.00M
414.60M
300.80M
EBT excluding unusual items
375.40M
277.30M
414.60M
300.80M
Income tax expense
69.90M
103.00M
107.00M
67.90M
Effective tax rate
24.00%
25.62%
25.81%
22.57%
Other operating expenses
400.50M
206.70M
464.90M
508.50M
Net income
221.30M
299.00M
307.60M
232.90M
Net profit margin
12.29%
16.90%
15.72%
11.81%
Earnings per share
-
-
-
-
Interest and investment income
-
96.70M
-
-
Interest expense
-2.50M
-3.90M
-6.30M
-7.80M
Net interest expenses
-2.50M
92.80M
-6.30M
-7.80M
Depreciation and amortization charges
53.80M
57.40M
59.00M
55.60M
EBITDA
395.75M
325.80M
426.40M
365.90M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps